Phase 2b Study of GSK4532990 in Adults With NASH

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

284

Participants

Timeline

Start Date

January 2, 2023

Primary Completion Date

January 26, 2026

Study Completion Date

April 5, 2027

Conditions
Nonalcoholic Fatty Liver DiseaseNon-alcoholic Fatty Liver Disease
Interventions
DRUG

GSK4532990

GSK4532990 will be administered.

DRUG

Placebo

Placebo will be administered.

Trial Locations (170)

1070

GSK Investigational Site, Brussels

1118

GSK Investigational Site, Ciudad AutOnoma de Buenos Aire

1200

GSK Investigational Site, Brussels

2650

GSK Investigational Site, Edegem

3000

GSK Investigational Site, Rosario

6000

GSK Investigational Site, Perth

6009

GSK Investigational Site, Nedlands

10029

GSK Investigational Site, New York

10033

GSK Investigational Site, New York

10075

GSK Investigational Site, New York

11527

GSK Investigational Site, Athens

15213

GSK Investigational Site, Pittsburgh

19610

GSK Investigational Site, Wyomissing

20089

GSK Investigational Site, Rozzano MI

20122

GSK Investigational Site, Milan

20770

GSK Investigational Site, Greenbelt

21045

GSK Investigational Site, Columbia

22332

GSK Investigational Site, Incheon

23229

GSK Investigational Site, Richmond

23236

GSK Investigational Site, Richmond

26504

GSK Investigational Site, Rio Patras

27599

GSK Investigational Site, Chapel Hill

27710

GSK Investigational Site, Durham

28034

GSK Investigational Site, Madrid

28041

GSK Investigational Site, Madrid

28222

GSK Investigational Site, Madrid

28557

GSK Investigational Site, Morehead City

29010

GSK Investigational Site, Málaga

30060

GSK Investigational Site, Marietta

30078

GSK Investigational Site, Snellville

30328

GSK Investigational Site, Sandy Springs

30607

GSK Investigational Site, Athens

33009

GSK Investigational Site, Hallandale

33016

GSK Investigational Site, Hialeah

GSK Investigational Site, Miami Lakes

33032

GSK Investigational Site, Homestead

33122

GSK Investigational Site, Miami

33126

GSK Investigational Site, Miami

33134

GSK Investigational Site, Coral Gables

33176

GSK Investigational Site, Miami

33401

GSK Investigational Site, West Palm Beach

33458

GSK Investigational Site, Jupiter

33907

GSK Investigational Site, Fort Myers

34209

GSK Investigational Site, Bradenton

34211

GSK Investigational Site, Lakewood Rch

35128

GSK Investigational Site, Padua

35209

GSK Investigational Site, Homewood

36071

GSK Investigational Site, Vigo

37040

GSK Investigational Site, Clarksville

37421

GSK Investigational Site, Raleigh

39008

GSK Investigational Site, Santander

41013

GSK Investigational Site, Seville

41126

GSK Investigational Site, Modena

41380

GSK Investigational Site, Kocaeli

44130

GSK Investigational Site, Guadalajara

44145

GSK Investigational Site, Westlake

44320

GSK Investigational Site, Akron

45066

GSK Investigational Site, Springboro

46202

GSK Investigational Site, Indianapolis

46635

GSK Investigational Site, South Bend

48038

GSK Investigational Site, Chesterfield

48075

GSK Investigational Site, Southfield

48109

GSK Investigational Site, Ann Arbor

48197

GSK Investigational Site, Ypsilanti

49933

GSK Investigational Site, Angers

50139

GSK Investigational Site, Florence

53200

GSK Investigational Site, Rize

54642

GSK Investigational Site, Thessaloniki

62170

GSK Investigational Site, Cuernavaca Morelos

66606

GSK Investigational Site, Topeka

67091

GSK Investigational Site, Strasbourg

69310

GSK Investigational Site, Pierre-Bénite

70006

GSK Investigational Site, Marrero

70072

GSK Investigational Site, Marrero

71013

GSK Investigational Site, San Giovanni Rotondo FG

71105

GSK Investigational Site, Shreveport

71201

GSK Investigational Site, Monroe

71220

GSK Investigational Site, Monroe

72117

GSK Investigational Site, North Little Rock

72401

GSK Investigational Site, Jonesboro

75203

GSK Investigational Site, Dallas

75651

GSK Investigational Site, Paris

76710

GSK Investigational Site, Waco

77030

GSK Investigational Site, Houston

77079

GSK Investigational Site, Houston

77909

GSK Investigational Site, Houston

78215

GSK Investigational Site, San Antonio

78229

GSK Investigational Site, San Antonio

78520

GSK Investigational Site, Brownsville

78539

GSK Investigational Site, Edinburg

78626

GSK Investigational Site, Georgetown

78757

GSK Investigational Site, Austin

80907

GSK Investigational Site, Colorado Springs

84088

GSK Investigational Site, West Jordan

85224

GSK Investigational Site, Chandler

85381

GSK Investigational Site, Mesa

85712

GSK Investigational Site, Chandler

87042

GSK Investigational Site, Limoges

89106

GSK Investigational Site, Las Vegas

90127

GSK Investigational Site, Palermo

90255

GSK Investigational Site, Huntington Park

91405

GSK Investigational Site, Van Nuys

92037

GSK Investigational Site, La Jolla

92064

GSK Investigational Site, Poway

92377

GSK Investigational Site, Rialto

92704

GSK Investigational Site, Santa Ana

92866

GSK Investigational Site, Orange

94115

GSK Investigational Site, San Francisco

95817

GSK Investigational Site, Sacramento

97000

GSK Investigational Site, Mérida

98105

GSK Investigational Site, Seattle

110070

GSK Investigational Site, New Delhi

160062

GSK Investigational Site, Chandigarh

395009

GSK Investigational Site, Surat

400012

GSK Investigational Site, Mumbai

441108

GSK Investigational Site, Nagpur

500003

GSK Investigational Site, Secunderabad

641005

GSK Investigational Site, Coimbatore

751019

GSK Investigational Site, Bhubaneswar

781006

GSK Investigational Site, Guwahati

52242-1009

GSK Investigational Site, Iowa City

08648

GSK Investigational Site, Princeton

07871

GSK Investigational Site, Sparta

17604-3200

GSK Investigational Site, Lancaster

C1061AAS

GSK Investigational Site, Buenos Aires

C1181ACH

GSK Investigational Site, Capital Federal

C1056ABJ

GSK Investigational Site, Ciudad Autonoma de Bueno

B1629AHJ

GSK Investigational Site, Pilar

T4000IHE

GSK Investigational Site, San Miguel de Tucumán

T2N 4Z6

GSK Investigational Site, Calgary

M5G 2C4

GSK Investigational Site, Toronto

546 42

GSK Investigational Site, Thessaloniki

00168

GSK Investigational Site, Roma

918-8503

GSK Investigational Site, Fukui

830-0011

GSK Investigational Site, Fukuoka

500-8513

GSK Investigational Site, Gifu

500-8717

GSK Investigational Site, Gifu

501-6062

GSK Investigational Site, Gifu

503-8502

GSK Investigational Site, Gifu

734-8551

GSK Investigational Site, Hiroshima

760-0017

GSK Investigational Site, Kagawa

760-8557

GSK Investigational Site, Kagawa

761-0793

GSK Investigational Site, Kagawa

890-8520

GSK Investigational Site, Kagoshima

216-8511

GSK Investigational Site, Kanagawa

236-0004

GSK Investigational Site, Kanagawa

259-1143

GSK Investigational Site, Kanagawa

390-8621

GSK Investigational Site, Nagano

856-8562

GSK Investigational Site, Nagasaki

634-8522

GSK Investigational Site, Nara

028-3695

GSK Investigational Site, Numakunai

700-8505

GSK Investigational Site, Okayama

564-0013

GSK Investigational Site, Osaka

849-8501

GSK Investigational Site, Saga

693-8501

GSK Investigational Site, Shimane

409-3898

GSK Investigational Site, Yamanashi

07206

GSK Investigational Site, Panama City

Unknown

GSK Investigational Site, Panama City

GSK Investigational Site, Yongsan-Ku Seoul

00927

GSK Investigational Site, San Juan

07061

GSK Investigational Site, Seoul

156-755

GSK Investigational Site, Seoul

08035

GSK Investigational Site, Barcelona

08208

GSK Investigational Site, Sabadell Barcelona

06800

GSK Investigational Site, Ankara

WS11 0BN

GSK Investigational Site, Cannock

SE5 9RS

GSK Investigational Site, London

M13 9NQ

GSK Investigational Site, Manchester

NE7 7DN

GSK Investigational Site, Newcastle upon Tyne

NG7 2UH

GSK Investigational Site, Nottingham

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT05583344 - Phase 2b Study of GSK4532990 in Adults With NASH | Biotech Hunter | Biotech Hunter